Search
for
Sort by
Research 931–960 of 1000+
- Granulomatous Alopecia Areata: A Rare Report With a Review
- “Effectiveness of minimally invasive injectable modalities in the management of androgenetic alopecia among adults—A systematic review”
- Improvement in health‐related quality of life and symptoms of anxiety and depression in patients with alopecia areata randomized to baricitinib or placebo: Results from two international randomized controlled trials
- Hair Follicle Classification and Hair Loss Severity Estimation Using Mask R-CNN
- Alopecia Areata and malignancies: uncertainties clarified by a large-scale population-based study
- Evaluation of platelet-rich plasma in treatment of alopecia areata
- Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients
- Improvement in Measures of Quality of Life and Symptoms of Anxiety and Depression in Patients with Severe Alopecia Areata Achieving Sustained Scalp Hair Regrowth with Baricitinib
- Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study
- Reply to: “Tofacitinib for the treatment of severe alopecia areata and variants”
- 42004 Scalp, eyebrow, and eyelash hair regrowth with continued ritlecitinib treatment among patients with alopecia areata without target efficacy response at Week 24: post hoc analysis of the ALLEGRO phase 2b/3 study
- Irish dermatologists’ experience with JAK inhibitors in alopecia areata
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- Molecular Predictors of Ritlecitinib Efficacy in Alopecia Areata: Role of JAK3-Dependent Inflammation and Follicular Integrity
- Clinical Benefits of Baricitinib Therapy According to Scalp Hair Regrowth in Patients with Severe Alopecia Areata
- 272 Dupilumab treatment in children with alopecia areata: A real-world, single-center observational study
- Criteria for Commencing and Continuing Subsidised Janus Kinase Inhibitor Therapy in Australian Alopecia Areata Patients—Results From an Australian Expert Consensus Exercise
- A Phase 1, Open‐Label Study of the Pharmacokinetics of Ritlecitinib in Children Aged 6–12 Years With Alopecia Areata
- Alopecia areata-like hair loss after a tick bite
- Autophagy and alopecia areata: is there a link?
- British Association of Dermatologists living guideline for managing people with alopecia areata 2025
- Combined microneedling with topical vitamin D3 or bimatoprost versus microneedling alone in the treatment of alopecia areata: A comparative randomized trial
- Clinical and demographic characteristics associated with nail involvement in alopecia areata: A cross‐sectional study of 197 patients
- Ivarmacitinib for the treatment of adults with severe alopecia areata: Results from a phase 3 trial
- Treatment Response to Diphenylcyclopropenone in Patients with Alopecia Totalis/Universalis
- Abrocitinib Treatment in Diffuse Alopecia Areata: A Case Report and a Literature Review
- Relapse of alopecia areata during ongoing Janus kinase inhibitor therapy is not uncommon and usually occurs in previously affected areas: A multicenter Italian real-world study
- TREATMENT OF ALOPECIA AREATA WITH ORAL METHYLPREDNISOLONE COMBINED WITH FRACTIONAL MICRONEEDLE RADIOFREQUENCY
- Successful Treatment of Coexisting Alopecia Areata and Bullous Pemphigoid With Dupilumab: A Case Report
- Pediatric and Adolescent Alopecia Areata Treated with JAK Inhibitors: Balancing Efficacy and Safety Across Clinical Trials